FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563669096> ?p ?o ?g. }

• W2563669096 abstract "Abstract Abstract 4775 From November 2002 to March 2006 in the centres of the region Marche participating in the study have been diagnosed 91 new cases of lymphoma B diffuse large cells in patients aged 65 years or more. All the 91 patients enrolled prospectively in our study were assessed on the basis of multidimensional geriatric evaluation (MGE). MGE analysed in detail the following aspects of elderly: Functional status, Socio-economic conditions, State cognitive, State emotional, Therapy pharmacology, State nutritional and every geriatric syndromes. On the basis of MGE we have identified 3 groups. The first group was composed of the patients who had no disability and that they could receive a standard chemotherapy with CHOP-Rituximab scheme. The second group of patients had at most 2 co-morbidities of moderate grade in the absence of geriatric syndromes. These patients have received a therapy chop-like with anthracycline liposomal peghilated (Caelyx). The third group composed of “frail patients” showed over the 85 years, 3 or more co-morbidities ADL <6 and one or more geriatric syndromes. These patients run therapy with chop scheme with reducing dose of 50%. 54 patients (59%) were allocated to the first group, 22 (25%) in the second and 15 (16%) in the third. In the first group, after the treatment, 82% has obtained the complete remission, and in the second and third group is obtained respectively in 64% and 60%. It was observed 1 death toxic to the first and third group and 2 in the second. Currently with a median follow-up of 55 months are live in complete remission 31 patients (57%) of the group 1, 7 patients (32%) of the group 2 and 3 patients (20%) of the group 3. The MGE has proven a useful instrument for an objective evaluation of elderly patients and has been possible to guide to the choice of therapy more appropriate also in patients that showed relevant co-morbidities. Disclosures: Offidani: Celgene: Honoraria; Janssen Cilag: Honoraria." @default.
• W2563669096 created "2017-01-06" @default.
• W2563669096 creator A5006386710 @default.
• W2563669096 creator A5014772053 @default.
• W2563669096 creator A5022230446 @default.
• W2563669096 creator A5022330993 @default.
• W2563669096 creator A5024306596 @default.
• W2563669096 creator A5028913158 @default.
• W2563669096 creator A5035913268 @default.
• W2563669096 creator A5044244099 @default.
• W2563669096 creator A5046956559 @default.
• W2563669096 creator A5050982431 @default.
• W2563669096 creator A5059060009 @default.
• W2563669096 creator A5059999219 @default.
• W2563669096 creator A5062179506 @default.
• W2563669096 creator A5065677406 @default.
• W2563669096 creator A5066257986 @default.
• W2563669096 creator A5071273767 @default.
• W2563669096 creator A5075520151 @default.
• W2563669096 creator A5083644983 @default.
• W2563669096 date "2009-11-20" @default.
• W2563669096 modified "2023-09-27" @default.
• W2563669096 title "Multicentric prospective Study of Differential Treatment for Elderly Patients Affected by Aggressive Non Hodgkin Lymphoma Based On a Geriatric Multidimensional Analysis." @default.
• W2563669096 doi "https://doi.org/10.1182/blood.v114.22.4775.4775" @default.
• W2563669096 hasPublicationYear "2009" @default.
• W2563669096 type Work @default.
• W2563669096 sameAs 2563669096 @default.
• W2563669096 citedByCount "0" @default.
• W2563669096 crossrefType "journal-article" @default.
• W2563669096 hasAuthorship W2563669096A5006386710 @default.
• W2563669096 hasAuthorship W2563669096A5014772053 @default.
• W2563669096 hasAuthorship W2563669096A5022230446 @default.
• W2563669096 hasAuthorship W2563669096A5022330993 @default.
• W2563669096 hasAuthorship W2563669096A5024306596 @default.
• W2563669096 hasAuthorship W2563669096A5028913158 @default.
• W2563669096 hasAuthorship W2563669096A5035913268 @default.
• W2563669096 hasAuthorship W2563669096A5044244099 @default.
• W2563669096 hasAuthorship W2563669096A5046956559 @default.
• W2563669096 hasAuthorship W2563669096A5050982431 @default.
• W2563669096 hasAuthorship W2563669096A5059060009 @default.
• W2563669096 hasAuthorship W2563669096A5059999219 @default.
• W2563669096 hasAuthorship W2563669096A5062179506 @default.
• W2563669096 hasAuthorship W2563669096A5065677406 @default.
• W2563669096 hasAuthorship W2563669096A5066257986 @default.
• W2563669096 hasAuthorship W2563669096A5071273767 @default.
• W2563669096 hasAuthorship W2563669096A5075520151 @default.
• W2563669096 hasAuthorship W2563669096A5083644983 @default.
• W2563669096 hasConcept C126322002 @default.
• W2563669096 hasConcept C141071460 @default.
• W2563669096 hasConcept C187212893 @default.
• W2563669096 hasConcept C188816634 @default.
• W2563669096 hasConcept C2779338263 @default.
• W2563669096 hasConcept C2780653079 @default.
• W2563669096 hasConcept C71924100 @default.
• W2563669096 hasConceptScore W2563669096C126322002 @default.
• W2563669096 hasConceptScore W2563669096C141071460 @default.
• W2563669096 hasConceptScore W2563669096C187212893 @default.
• W2563669096 hasConceptScore W2563669096C188816634 @default.
• W2563669096 hasConceptScore W2563669096C2779338263 @default.
• W2563669096 hasConceptScore W2563669096C2780653079 @default.
• W2563669096 hasConceptScore W2563669096C71924100 @default.
• W2563669096 hasLocation W25636690961 @default.
• W2563669096 hasOpenAccess W2563669096 @default.
• W2563669096 hasPrimaryLocation W25636690961 @default.
• W2563669096 isParatext "false" @default.
• W2563669096 isRetracted "false" @default.
• W2563669096 magId "2563669096" @default.
• W2563669096 workType "article" @default.